Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling

The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Conraux, Laurence, Pech, Catherine, Guerraoui, Halim, Loyaux, Denis, Ferrara, Pascual, Guillemot, Jean-Claude, Meininger, Vincent, Pradat, Pierre-François, Salachas, François, Bruneteau, Gaëlle, Le Forestier, Nadine, Lacomblez, Lucette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818176/
https://www.ncbi.nlm.nih.gov/pubmed/24224000
http://dx.doi.org/10.1371/journal.pone.0079733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818176/
https://www.ncbi.nlm.nih.gov/pubmed/24224000
http://dx.doi.org/10.1371/journal.pone.0079733

Ejemplares similares